Workflow
MT Højgaard Holding A/S: Enemærke & Petersen to construct two residential facilities in the ByK & TRUST partnership
Globenewswire· 2025-11-03 19:50
项目合同核心信息 - MT Højgaard Holding旗下业务部门Enemærke & Petersen通过ByK & TRUST合作体获得两份总包合同,总价值为3.2亿丹麦克朗 [1] - 合同涉及在哥本哈根Brønshøj区建设Rønnebo住宅设施,以及在Nørrebro区建设Jagtvej住宅设施 [1] Rønnebo住宅设施项目详情 - Rønnebo项目将建设约6,300平方米,包含64套住宅,预计2026年1月开工,2028年5月交付 [2] - 项目旨在为有精神疾病和社会困难的居民创造最佳环境,并配备各类共享功能 [2] - 在建设前,公司负责拆除现有建筑,并与哥本哈根市等合作,专注于空心混凝土板的再利用和知识共享 [2] Jagtvej住宅设施项目详情 - Jagtvej项目将于2025年秋季开工,预计2027年11月完工,建设约2,700平方米,包含24套面向弱势居民的住宅 [3] - 建筑将配备一个与公共城市空间(含足球场)共享的户外区域 [3] - 建设前拆除工作注重材料回收,回收材料用于哥本哈根市的其他建设项目 [3] 公司管理层评论与业务展望 - 公司首席运营官表示期待继续合作,并将借鉴此前在哥本哈根南港区Sluseholmen设计和建造24小时住宅设施的经验 [4] - 该订单不影响公司2025年财务展望,收入仍预计为100-105亿丹麦克朗,营业利润预计为4-4.5亿丹麦克朗 [5] - 订单确认了公司在多年建筑合作项目中的强势地位 [5] 行业合作背景 - Enemærke & Petersen自2016年起与哥本哈根市建立多年建筑合作伙伴关系,先后参与TRUST I和TRUST II合作体 [6] - ByK & TRUST合作体其他参与者包括Dominia、Kragh & Berglund、Lytt Architecture等多家行业公司 [6]
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
Globenewswire· 2025-11-03 19:45
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemonstrated encouraging anti-tumor activity and manageable safety profile of pumitamig (BNT327/BMS986545), a bispecific antibody candidate targeting PD-L11 and VEGF-A, in first disclosed interim data from global Phase 2 trial in extensive-stage small cell lung cancer Plan to initiate additional pivotal trials for pu ...
Descartes Sets Date to Announce Third Quarter Fiscal 2026 Financial Results
Globenewswire· 2025-11-03 19:45
WATERLOO, Ontario and ATLANTA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (TSX: DSG) (Nasdaq: DSGX), the global leader in uniting logistics-intensive businesses in commerce, is scheduled to report its third quarter fiscal 2026 financial results after market close on Wednesday, December 03, 2025. Members of Descartes' executive management team will host a conference call to discuss the company's financial results at 5:30 p.m. ET on Wednesday, December 03, 2025. Designated numbers are +1 289 51 ...
Freshpet CEO to Adopt Rule 10b5-1 Trading Plan
Globenewswire· 2025-11-03 19:31
BEDMINSTER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that Billy Cyr, Chief Executive Officer, and various family members and independently managed trusts established for his family, intend to adopt prearranged trading plans in order to exercise options granted in 2016 which expire on September 6, 2026 and to sell shares necessary to cover the exercise price, taxes and various estate planning needs. These plans will not include any ot ...
Beijing Marathon unites tradition, spirit in dual Olympic city
Globenewswire· 2025-11-03 19:30
BEIJING, Nov. 03, 2025 (GLOBE NEWSWIRE) -- With a history of more than four decades, the Beijing Marathon's iconic route from Tian'anmen Square to the Olympic Park has been a primary attraction for runners worldwide, and over 30,000 runners took part in the 2025 edition on Sunday. A Media Snippet accompanying this announcement is available by clicking on this link. "Tian'anmen Square is the heart of China's capital city. Starting from the square brings a sense of pride to me and really means a lot," said X ...
Freshpet, Inc. Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-11-03 19:30
Net Sales Growth of 14% Outperforms CategoryCompany Achieves Positive Free Cash Flow in Third Quarter and Now Expects to be Free Cash Flow Positive in 2025Updates 2025 Guidance BEDMINSTER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its third quarter and nine months ended September 30, 2025. Third Quarter 2025 Financial Highlights Compared to Prior Year Period Net sales of $288.8 million, an increase of 14.0%.Gross ...
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Globenewswire· 2025-11-03 19:30
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development; reiterates planned data readout in Q1 2026 Enacted ~30% workforce reduction to focus clinical development on heme program and initiate pre-clinical development of in vivo-engineered TCR-T for solid tumors Strategic prioritization extends cash runway into H2 2027 Conference call and webcast s ...
Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Globenewswire· 2025-11-03 19:30
Recorded $51.7 million in net product sales of YUTREPIA™ as launch momentum continuesAchieved profitability in the first full quarter of YUTREPIA salesMore than 2,000 unique patient prescriptions and 1,500 patient starts to dateCompany to host webcast today at 8:30 a.m. ET MORRISVILLE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, ...
Planet 13 Streamlines Footprint to Focus on Core Growth Markets
Globenewswire· 2025-11-03 19:30
Planet 13 Divests Non-Core Orange County Store and Closes Coalinga Cultivation FacilityLAS VEGAS, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the “Company”), a leading vertically-integrated multi-state cannabis company, today announced the divestiture of its non-core Orange County, California retail store and the closure of its cultivation facility in Coalinga, California. These actions mark another step in Planet 13’s strategy to focus resources on it ...
ParaZero to Showcase its Cutting-Edge Anti-Drone Technology at Milipol Paris 2025, the Leading Homeland Security and Safety Event
Globenewswire· 2025-11-03 19:28
公司近期动态 - ParaZero Technologies Ltd (纳斯达克 PRZO) 宣布将参加于2025年11月18日至21日举行的Milipol Paris 2025展会 [1][2] - 这是公司首次向广泛的国际观众展示其高性价比的反无人机系统 [1] - 公司将在以色列馆的5C-050展位展示其DefendAir反无人机解决方案 [1] 展会与市场平台 - Milipol Paris 2025是在法国内政部赞助下举办的世界领先的国土安全与安全创新活动 [2] - 预计将汇聚超过30,000名参观者和1,100家参展商 [2] - 该双年展是执法、民防、反恐和公共安全专业人士探索应对不断演变威胁的尖端解决方案的全球平台 [2] 产品与技术展示 - 公司将重点展示其DefendAir系列反无人机产品 该产品系列旨在对未经授权的无人机进行快速、非动力的拦截 [3] - DefendAir系统在最近的现场试验演示中实现了100%的拦截成功率 [3] - 产品线包括手持式DefendAir Net发射器、具备360度自主覆盖能力的先进固定式DefendAir炮塔系统 以及无人机载反无人机解决方案 [3] - 这些解决方案利用公司最初为自主无人机降落伞开发的专利技术 为城市、军事和关键基础设施环境提供精确、安全且可扩展的防御 [3] 业务进展与市场认可 - 公司的系统已获得来自一家全球主要一级国防公司的实质性订单 并已部署于世界各地的关键行动中 [4] 公司背景与业务范围 - ParaZero Technologies Ltd 是一家航空航天防御公司 专注于为全球有人和无人航空系统行业提供智能自主解决方案 [5] - 公司成立于2014年 由航空专业人士和无人机行业资深人士创立 是先进无人机技术领域的公认领导者 [5] - 公司产品组合包括用于航空安全和法规遵从的自主降落伞回收系统SafeAir 用于在战场和城市环境中防御敌对无人机的反无人机网发射平台DefendAir 以及精确空投系统DropAir [5]